Brian Adams - Nov 15, 2021 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
General Counsel
Signature
/s/ Brian Adams
Stock symbol
RLAY
Transactions as of
Nov 15, 2021
Transactions value $
-$203,450
Form type
4
Date filed
11/16/2021, 06:07 PM
Previous filing
Sep 27, 2021
Next filing
Dec 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Options Exercise $26.8K +6.5K +25.71% $4.12 31.8K Nov 15, 2021 Direct F1, F2
transaction RLAY Common Stock Sale -$230K -6.5K -20.45% $35.42 25.3K Nov 15, 2021 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLAY Stock Option (Right to Buy) Options Exercise $0 -6.5K -4.41% $0.00 141K Nov 15, 2021 Common Stock 6.5K $4.12 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020.
F2 Includes 13,887 shares underlying RSUs.
F3 This transaction was executed in multiple trades at prices ranging from $35.03 to $35.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.